chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Visited Doctor on April 7, 2011 for routine discussion on cholesterol and discuss what vaccinations I should have. I was administered two vaccinations around 5:00 pm, one in each arm: T-DAP and PNEUMO. The PNEUMO would be my 2nd pneumonia vaccination. First one would have been over 10 years ago. I had a tetanus shot by a public offering in 2009. I asked doctor if it was OK to take both at same time and he said yes. I developed symptoms of difficulty breathing, awful pain in arm where pneumonia vaccination was given and arm turned red with rash and ballooned twice the size of the arm in the next 5 hours. Couldn't get rest and by morning all symptoms worsened. Pain was so intense you could not touch the arm. Arm continued to swell up 6 inches in length on all sides of vaccination. I was very weak with no energy. In fact I had to take off work on April 8 as was too sick and weak. This continued all weekend into the next week and eventually had to take off work 4-13 all days. The physician's assistant said it might be from an infected needle which is why she wanted me to go on anti-biotics. I feel the medicine in the vaccination was BAD and or contained a substance that was toxic, spoiled or caused allergic reaction in me that could have killed me if my breathing would have continued to get worse. I live in a rural area so it is not easy to get to the emergency room as it is 40 minutes away. I live alone so I could not drive myself there so just tried to stay calm and take medicines that were prescribed.
Narrative:  75yo male died on 5-22-22 at skilled nursing facility. Pt had received a covid J&J vaccine on 6/9/2021. It appears death is not related to this vaccine. Pt with declined dementia.
Redness, swelling, RU extremity down to medical elbow area. No axillary adenopathy. Trt: ice packs, elevation, antihistamines. Seen by Dr.
Vaccine given at 11:58am. Patient started showing symptoms of anaphylaxis at 12:02pm. Patient was barely able to communicate, said she was having trouble breathing and wheezing. Pharmacist gave Epipen 0.3mg IM at 12:04pm while manager called 911. This seemed to give some relief.  Fire department and ambulance arrived shortly after. They took blood pressure and oxygen was checked.  Patient  put on oxygen and taken to  hospital.
3rd pfizer corona vaccine received; 3rd pfizer corona vaccine received; arm swelled; arm swelled,hot; itching; This is a spontaneous report from a contactable other healthcare professional received . A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in the arm on 27Aug2021 as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunization (at the age of 68-years-old). Medical history included ongoing breast cancer. Concomitant medication(s) included denosumab (PROLIA) taken for an unspecified indication from 24Aug2021 to 24Aug2021, in arm and letrozole taken for an unspecified indication, 7 days with letrozole. The patient previously took ibrance, from 26Jul2021, 100 mg daily for breast cancer, 21 days off, on hold due to labs continue to be low. Historical vaccine included first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as dose 1 and dose 2, single for COVID-19 immunization. It was reported that, on an unspecified date in 2021, patient experienced arm swelled, hot and itching from 3rd pfizer corona vaccine received on 27Aug21. The clinical outcome for the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
2 weeks of fever, severe lethargy, nausea, dizzy, severe fatigue, muscle pain,  pain
Swelling of Knuckles of right hand; Cannot make fist; Soreness in Knuckles of right hand; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand). At the time of the report, SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Large area of redness, swelling below the injection site, extending almost to the elbow.  Redness continues on day three, following vaccination.
Pain injection site, which pain increased until it went away on 3rd day. Nausea, loose stools,headache, achiness. All left on 3rd day.
48 hours post vaccine administration pt. developed urticaria, fever, and joint swelling. Probable SSLR.
Patient received her second dose of the Pfizer COVID-19 vaccine Friday, June 4th, 2021. One day after the second Pfizer Covid 19 shot, (Saturday, June 5th, 2021), Patient experienced fever, fatigue, weakness and swollen lymph nodes. Two days after the second Pfizer Covid 19 shot, (Sunday, June 6th, 2021), Patient still had those symptoms in addition to the break out of several painful genital laisons. She visited her pediatrician Tuesday, June 8th, 2021, and the laisons were tested for the herpes virus. Patient was also prescribed oral antiviral medication, and topical steroid creams. The results for the herpes test came out negative. Today, June 11th 2021, the  laisons are still present and painful, and continue to be treated.
Patient called pharmacy and said her arm was very sore and red above the elbow. I suggested that she put ice on it and she said she already had and it was still painful to even lift her arm. I told her to come in and I would look at her arm. I also asked why she got both shots in the same arm and she said because she had a steroid shot in the left arm and asked for both to be put in the right arm. When I saw her arm, it was red from her elbow to at least 4 inches up her arm. Pharmacy paid for her to go to the walk in clinic a block away and the doctor there diagnosed her with cellulitis. We filled a prescription tonight for her for cephalexin and MEDROL dose pack.
I had my second dose in the same arm as the first. The day after I slept for 15 hours. Two days after the second dose of the vaccine I had a painful lump under my arm near my arm. My Lymph node was swollen under my right arm which was the arm that I got the shot was given. It was a +2 Edema and I had two nodes that I could feel. It resolved within a few days using warm compresses.
Developed area of redness warm & firmness at site after receiving immunizations (MMR & PREVNAR) in his right leg on 11April12. Patient was briefly assessed 12April12 by doctor when his mother walked into clinic with him. On 12April12 the redness was 3-4 cm, warm & slightly firm. Was advised to use cold compress for comfort & ibuprofen. Pt came back in 13April12, The area of redness has increased but is without swelling, warmth or sign of infection. Pt is a bit fussy, but without systemic symptoms, per doctor. Normal appetite, activity, sleeps, voids, stools are all normal. Mom has been using ibuprofen twice daily for discomfort.
My arm had been itching and I noticed hives on my arm in the area that I received the shot. It has been 24 hours since I noticed the hives. They are still there. I have not gone to the doctor.
back and joints pain; cough; headache; back and joints pain; lack of efficacy; Positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back and joints pain), COUGH (cough), DRUG INEFFECTIVE (lack of efficacy), SARS-COV-2 TEST POSITIVE (Positive for Covid) and HEADACHE (headache) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Sep-2021, the patient experienced DRUG INEFFECTIVE (lack of efficacy) and SARS-COV-2 TEST POSITIVE (Positive for Covid). On an unknown date, the patient experienced BACK PAIN (back and joints pain), COUGH (cough), HEADACHE (headache) and ARTHRALGIA (back and joints pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (back and joints pain), COUGH (cough), DRUG INEFFECTIVE (lack of efficacy), SARS-COV-2 TEST POSITIVE (Positive for Covid), HEADACHE (headache) and ARTHRALGIA (back and joints pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Sep-2021, SARS-CoV-2 test: positive (Positive) Result : Patient  tested positive for Covid 19 via rapid test.         No Concomitant medications were reported.; Sender's Comments: Covid infection following vaccination has a causality assessment of "not applicable" by convention.  Other events captured are likely symptoms of the Covid infection but a causal relationship cannot be excluded.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 32-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Latex allergy. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) from 12-Mar-2020 to an unknown date for Anxiety.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Jun-2020 and the estimated date of delivery was 20-Mar-2021. On 04-Feb-2021 at 3:30 PM, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy. The vaginal delivery occurred on 09-Mar-2021, which was reported as Full-term. For neonate 1, the birth weight was 3000 grams (6lbs 10oz) with an APGAR score of 9 and 9 at (1, 5 minutes). The outcome was reported as Term Birth w/o Complications. Fetus length is 51 with head circumference of 32.5 . On 04-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Aug-2020, Ultrasound scan: normal (normal) Nuchal scan -Normal. On 29-Oct-2020, Ultrasound scan: normal (normal) Anatomy scan -Normal. On 01-Jul-2021, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Glucose screen was performed on 12-MAR-2021 result was normal . Patient reported that her first son who was 5 years old was diagnosed as ASD .  No treatment information provided.  The patient given birth of male baby. The baby's weight was 3 kg, length was 51 cm, head circumference was 32.5 cm. APGR score was 9.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Pregnancy Outcome Form (update reporter, concomitant medications and patient details)
12 minutes post injection I felt a tingling warm feeling around the injection site in my left upper arm. This tingling and warmth moved into my chest directly into my heart and when it did I experienced tachycardia. Then, the warmth went up into my neck and then my ears started ringing. I was recommended to go to the ER down the hall where an EKG was performed. All vitals and EKG were normal. This episode lasted 30 min. I was not anxious prior to this event occuring.
Lupus-like butterfly rash appeared pinkish 6 day after the first shot.  A black spot appeared on nose side of nose two weeks after first shot and both sides of chin began to turn pinkish/red.  Six weeks later, received second shot.   One week after the second shot, the black spot on the nose slowly began to spread (noticeable every other day).   Two weeks after second shot, pinkish butterfly rash (both cheeks and across nose)  as well as both sides of chin began to get darker and spread.
Was watched for 30 minutes, felt a little funny, but left the site after 30 minutes was up. got barely down the road and had to pull over. Felt Flushed and hot around neck area and thought I might faint. Felt a slight lump in throat. Drove back to fair ground site and asked to be looked at. Symptons did not get worse and started to ease as Paramedics on site took blood pressure& cardiogram. Cardio was good and blood pressure was 178/81.  Flushing disappeared, lump in throat 98% better. Refused further treatment and drove home,  Was OK thereafter.
ringing in my ears, which occurs randomly throughout the day. I have never previously had this happen in my life.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 67-year-old male patient who received SHINGRIX for prophylaxis.  On 3rd October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema, injection site muscle pain and injection site itching. On an unknown date, the outcome of the injection site erythema, injection site muscle pain and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site erythema, injection site muscle pain and injection site itching to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in the left deltoid. The pharmacist reported that the issues the patient experienced resolved in one week.
Pt's first indication was vomiting, lethargy, followed by a bright red rash, head-toe, later labled erythema multiforme. Continued vomiting, weakness Dec 21-25. Admitted to ER, IV, bloodwork revealed elevated glucose levels with virus. Initiated diagnosis 12/27 of diabetes mellitus (type I) and transferred and confirmed diagnosis. Continued IV, administered insulin intensive regimen. THe hospital discharge summary states ketoacidosis. The vaccine recipient developed Type 1 Juvenile Diabetes approximately 12 days following the vaccination, as her auto-immune system was attacked. This is a permanent, irreversible condition.
Continuous non productive every 20 seconds for eight hours. Unable to sleep because of cough. Symptoms started about eight hours after vaccine administered.  Other than fatigue total resolution of symptoms next morning .
Patient was on our scheduled today for a Covid vaccination. Patient received a flu vaccination today by mistake. Patient already received a flu vaccination on 11/2/2023. I did not realize error until I went to document in patient's chart. Office manager notified. Patient's PCP and Supervising physician notified. I called and spoke with patient's husband. He stated everything was ok and asked that I schedule patient for Covid vaccination.
This spontaneous report as received from a consumer refers to a 50 year old male patient with sulfonamides allergy. On 03-MAY-2013 the patient was vaccinated with ZOSTAVAX (Lot # not reported) subcutaneous (dose not reported) for prevention of shingles. Concomitant therapies included VYTORIN and PRINIVIL. The patient reported that on 05-MAY-2013, the patient experienced large histamine base reaction that is 6 inches by 6 inches around the injection site on his left arm after receiving ZOSTAVAX. The patient sought medical attention at urgent care visit. Treatment was given with BENADRYL. The outcome of the patient experienced large histamine base reaction that is 6 inches by 6 inches was reported as recovering/resolving. Additional information is not expected.
sick for 6 weeks; Initial information received on 09-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer or non-healthcare professional.  This case is linked to case 2020SA285333 (same reporter).  This case involves patient (unknown demographics) who got sick for 6-weeks (illness), when received INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick for 6-weeks (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for illness.  There will be no information available on the batch number for this case.
Spotting/bleeding 2 days after 2nd dose.; Spotting/bleeding 2 days after 2nd dose.; This is a spontaneous report from a non-contactable consumer (patient). A 54-year-old female patient received the second dose of BNT162B2, via an unspecified route of administration in left arm on 26Apr2021 at single dose for COVID-19 immunisation. Medical history included COVID-19 diagnosed prior to vaccination and menopause for 2 years. Concomitant medications received within 2 weeks of vaccination included vitamins. Patient previously received the first dose of BNT162B2 for COVID-19 immunisation. Patient experienced spotting/bleeding 2 days after the second dose on 28Apr2021. Since the vaccination, the patient had not been tested for COVID-19. No treatment was received. Outcome of the events was not resolved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Get a fever; Can't  move my hand  for a little bit; It hurt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced fever (Verbatim: Get a fever), mobility decreased (Verbatim: Can't  move my hand  for a little bit) and pain (Verbatim: It hurt). The outcome of the fever, mobility decreased and pain were not reported.   It was unknown if the reporter considered the fever, mobility decreased and pain to be related to Shingles vaccine.     It was unknown if the company considered the fever, mobility decreased and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 02-Jul-2023 This case was reported the patient via interactive digital media. The patient got the shot and got fever the next day. Vaccine hurt and not able to move hand for a little bit. The time to onset for mobility decreased and pain was unknown Follow-up not possible as no contact details provided.
The patient had checked about need of receiving second shingrx shot but patient was hesitant because of event experienced after 1st shot.; severe itching on arms and legs; This case was reported by a consumer via call center representative and described the occurrence of pruritus in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced pruritus and incomplete course of vaccination. On an unknown date, the outcome of the pruritus was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pruritus to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported but patient could be 64 or 63 years old at time of vaccination. The patient received 1st shot one and a half years ago from date of reporting and  had severe itching on arms and legs for 3 months. The patient had checked about need of receiving second shingrx shot but patient was hesitant because of event experienced after 1st shot. Till the time of reporting patient did not receive 2nd dose of Shingrix which led to incomplete course of vaccination.
Father called on 7/12/17. Chief complaint: reaction to MMR, low grade fever, headache, today nausea and vomiting but may be related to workout, also had meningococcal vaccine the same day. Associated symptoms: did develop joint pain in her wrists for the past two days. Duration/Onset: shot was given 6/24/17. Pertinent history: Raynaud's and positive ANA. Aggravated by: vaccine. Alleviated by: nothing. Denied symptoms: no rash, seizures, SOB. Telephone encounter sent to Dr. and her reply: Pt appears to have had mild reaction to MMR, these symptoms are already known possible reactions from MMR. If father would like reported, we can do so. I would recommend she get second dose, but if father concerned, recommend he discuss with her rheumatologist.
Patient developed erythema at injection site, irregular border, 1 inch x 2 inches.
p/vax pt devel a fever of 104 which resolved w/in 2 days & diarrhea
Headache, Fever, Diarrhea, NauseaVomiting, chills Narrative:
pt recvd vax; exp fever, under eyes very warm; sick to his stomach & a very dry mouth;pt told if get worse to go to MD;
This spontaneous report as received from a nurse refers to an unspecified number of unspecified patients of unknown age and gender. On unknown dates, the patients received dose of PNEUMOVAX 23, that had been improperly stored (lot #, expiration date, route, dose and frequency not provided). No adverse experience was reported. A telephone attempt to obtain follow-up information on 23-MAR-2015 was unsuccessful. The nurse could not supply the information regarding lot numbers, expiration dates and patient identification information at the time of the call. The reporter confirmed that there had been no reports of adverse events following administration of the vaccinations. This is one of several reports received from the same reporter. Additional information has been requested.
No side effects from the shot. It was until February 3-4, I contracted COVID-19, a very high temperature of 103, very achy, cough, slight headache. I had a COVID-19 test and it Positive and called the doctor and she prescribed Paxlovid.  I was isolated for 10 days, wear a mask for 5 days, on the 3rd day I was fever free. I had an issue with my ear, doctor said it could be a COVID related - I had an infection.
erythematous rash w/fine vesicles lt thigh; black eschar lesion w/mild sloughing skin lt upper arm; also pale, lethargic;